Patent · US Expired

Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom

US7491825B2 · kind B2 · utility

0Cited by
5References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 2003
Grant dateFeb 17, 2009
Priority date
Expiry dateDec 14, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D215/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Non-peptide compounds of formula (I) having activity as specific antagonists of bradykinin (BK) B2 receptor. The compounds are chemically characterized by the presence of an alpha, alpha-disubstituted amino acid at least one amino group, free or salified, or the corresponding ammonium quaternary salt. These BK receptor antagonists are a novel class of medicaments which can be used in all the disorders in which the receptors are involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.